Constant voltage 'Iron'tophoresis

被引:10
作者
Vaka, Siva Ram Kiran [1 ]
Shivakumar, H. N. [1 ]
Murthy, S. Narasimha [1 ]
机构
[1] Univ Mississippi, Dept Pharmaceut, University, MS 38677 USA
关键词
Ferric pyrophosphate; transdermal; constant voltage iontophoresis; electroporation; anemia; IRON-DEFICIENCY ANEMIA; SKIN ELECTROPORATION; DELIVERY; SUPPLEMENTATION; IONTOPHORESIS; HEMODIALYSIS; TRANSFERRIN;
D O I
10.3109/10837450.2010.492219
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to investigate the feasibility of rapid administration of iron via transdermal route as an alternative to parenteral route of administration. In vitro drug delivery studies were carried out using porcine epidermis mounted on Franz diffusion cells. The effect of chemical permeation enhancers and physical techniques (constant voltage iontophoresis, electroporation and combination of electroporation with iontophoresis) on the transport of ferric pyrophosphate (FPP) was studied. Transepidermal water loss (TEWL) and electrical resistance were measured in order to see the effect of these techniques on the skin barrier function. The amount of FPP permeated was not enhanced significantly with the use of any of the enhancers (P > 0.05). It was found that constant voltage iontophoresis (0.5, 2 or 4 V) for about 30 min across electroporated epidermis (120 V, 100 pulses, 10 ms at 5 Hz) enhanced the delivery of FPP over control in the range of 2- to 42-fold. Hence, a therapeutically required dose of iron could be delivered by transdermal route using electrically-mediated techniques.
引用
收藏
页码:483 / 488
页数:6
相关论文
共 19 条
[1]   Transdermal iontophoretic delivery of salmon calcitonin [J].
Chang, SL ;
Hofmann, GA ;
Zhang, L ;
Deftos, LJ ;
Banga, AK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 200 (01) :107-113
[2]   Diagnosis and management of iron-deficiency anaemia [J].
Cook, JD .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (02) :319-332
[3]   THE RATIONALE FOR TREATING IRON-DEFICIENCY ANEMIA [J].
CROSBY, WH .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (03) :471-472
[4]   Skin electroporation for transdermal and topical delivery [J].
Denet, AR ;
Vanbever, R ;
Préat, V .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (05) :659-674
[5]  
Ferry L L, 1995, Pharm Acta Helv, V70, P43, DOI 10.1016/0031-6865(94)00050-6
[6]   Dialysate iron therapy: Infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis [J].
Gupta, A ;
Amin, NB ;
Besarab, A ;
Vogel, SE ;
Divine, GW ;
Yee, J ;
Anandan, JV .
KIDNEY INTERNATIONAL, 1999, 55 (05) :1891-1898
[7]   INTRAVENOUS IRON DEXTRAN IN CLINICAL MEDICINE [J].
HAMSTRA, RD ;
BLOCK, MH ;
SCHOCKET, AL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (17) :1726-1731
[8]  
Killip S, 2007, AM FAM PHYSICIAN, V75, P671
[9]   Body iron and individual iron prophylaxis in pregnancy - should the iron dose be adjusted according to serum ferritin? [J].
Milman, Nils ;
Byg, Keld-Erik ;
Bergholt, Thomas ;
Eriksen, Lisbeth ;
Hvas, Anne-Mette .
ANNALS OF HEMATOLOGY, 2006, 85 (09) :567-573
[10]   IRON EXCHANGE BETWEEN TRANSFERRIN MOLECULES MEDIATED BY PHOSPHATE COMPOUNDS AND OTHER CELL METABOLITES [J].
MORGAN, EH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 499 (01) :169-177